Mylan N V Asset Turnover Ratio (MYL), as of third quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mylan N v   (NASDAQ: MYL)
 

Mylan N V Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Mylan N V 's asset turnover ratio has remained unchanged compare to previous quarter at 0.38 in the third quarter (Sep 30 2020)

Within sector 92 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2020, to 2504, from total ranking in the second quarter 2020 at 2548.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYL Asset Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Asset Change -1.5 % -7.57 % -5.52 % -4.52 % -7.18 %
Y / Y Revenue Change 0.35 % -4.22 % 4.96 % 3.67 % 3.47 %
Asset Turnover Ratio (TTM) 0.38 0.38 0.37 0.37 0.36
MYL's Total Ranking # 2504 # 2548 # 2629 # 2936 # 2742
Seq. Asset Change 4.01 % -2.45 % -3.55 % 0.65 % -2.4 %
Seq. Revenue Change 8.82 % 4.28 % -17.94 % 7.77 % 3.86 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 93
Healthcare Sector # 339
Overall Market # 2504

Asset Turnover Ratio Statistics
High Average Low
0.72 0.47 0.33
(Dec. 31. 2006)   (Mar 31 2018)




MYL Company Profile • Back to MYL Efficiency Comparisons • Compare MYL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2020 Assets at quarter ending Sep 30 2020
Rayont Inc   1.02 $ 1.559  Millions$ 1.524  Millions
Grapefruit Usa Inc   1.02 $ 2.700  Millions$ 2.657  Millions
Conformis inc   1.01 $ 71.953  Millions$ 70.894  Millions
Antares Pharma Inc   1.01 $ 143.305  Millions$ 142.063  Millions
Yunhong Green Cti Ltd   0.99 $ 25.850  Millions$ 26.093  Millions
Electromed Inc   0.99 $ 32.172  Millions$ 32.491  Millions
Adapthealth Corp   0.98 $ 857.501  Millions$ 874.024  Millions
Rockwell Medical inc   0.98 $ 62.523  Millions$ 63.741  Millions
Quidelortho Corp  0.98 $ 1,004.643  Millions$ 1,024.981  Millions
Vystar Corporation  0.98 $ 21.134  Millions$ 21.609  Millions
Inotiv Inc   0.98 $ 60.469  Millions$ 61.975  Millions
Neurometrix Inc   0.97 $ 7.275  Millions$ 7.511  Millions
Invacare Holdings Corporation  0.97 $ 859.559  Millions$ 887.788  Millions
Psychemedics Corporation  0.97 $ 24.740  Millions$ 25.624  Millions
Puma Biotechnology Inc   0.96 $ 235.475  Millions$ 246.486  Millions
Elite Pharmaceuticals Inc   0.95 $ 24.939  Millions$ 26.197  Millions
Ufp Technologies Inc   0.95 $ 184.480  Millions$ 195.214  Millions
Genmark Diagnostics Inc   0.94 $ 148.670  Millions$ 158.167  Millions
Universal Health Services Inc   0.94 $ 11,368.209  Millions$ 12,103.233  Millions
Venus Concept Inc   0.94 $ 150.958  Millions$ 161.081  Millions
Acadia Healthcare Company Inc   0.93 $ 6,420.164  Millions$ 6,883.878  Millions
Novocure Limited  0.93 $ 449.647  Millions$ 485.471  Millions
Ironwood Pharmaceuticals inc   0.92 $ 399.144  Millions$ 435.654  Millions
Lhc Group Inc   0.90 $ 2,062.190  Millions$ 2,291.503  Millions
Protalix Biotherapeutics inc   0.90 $ 61.162  Millions$ 68.072  Millions
Esperion Therapeutics Inc   0.90 $ 218.891  Millions$ 243.853  Millions
Tandem Diabetes Care Inc   0.90 $ 439.163  Millions$ 489.666  Millions
Catalyst Pharmaceuticals Inc   0.88 $ 118.180  Millions$ 134.132  Millions
Harrow Inc   0.87 $ 46.880  Millions$ 53.726  Millions
Waters Corporation  0.87 $ 2,295.001  Millions$ 2,637.790  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.